 |
 |
 |
 |
|
|
|
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Your Online Resource for Diabetes Treatment
Home > National Diabetes Education Initiative :...
 | Printer-Friendly Format |
 | Email this to a friend |
 | Add to my Favorites |
| |
NDEI Mission Statement
The National Diabetes Education Initiative® is a multicomponent educational program on designed for endocrinologists, diabetologists, cardiologists, primary care physicians, and other healthcare professionals involved in the care and management of patients with type 2 diabetes. NDEI programs address issues concerning resistance and type 2 diabetes, from the epidemiology and pathophysiology of the disease and its associated complications to the therapeutic options for treatment and prevention.
Educational Objectives
After completion of NDEI programs, participants should be better able to:
| • | Implement for the treatment of type 2 diabetes, with a specific focus on achieving target A1C and serum glucose levels |
| • | Manage the spectrum of patients with insulin-resistant states, from impaired glucose tolerance to type 2 diabetes |
| • | Understand the contribution of resistance to the pathophysiology of type 2 diabetes |
| • | Describe the link between complications and resistance |
| • | Understand the rationale for early, aggressive intervention to prevent and complications of type 2 diabetes |
| • |
Describe the mechanism of action, efficacy, and safety of available pharmacotherapeutic agents for the management of type 2 diabetes, and understand the role each agent plays in patient management |
|
NDEI Education Council Co-Chairmen | |
| Edward S. Horton, MD | Vice President and Director of Clinical Research Joslin Diabetes Center Professor of Medicine Harvard Medical School Boston, Massachusetts |
Burton E. Sobel, MD |
Professor of Medicine and Director Cardiovascular Research Institute University of Vermont College of Medicine Colchester Research Facility and Consulting Cardiologist Fletcher Allen Health Care Burlington, Vermont |
Faculty | |
| David L. Bronson, MD, FACP Council Emeritus |
Associate Professor of Internal Medicine The Ohio State University Chair, Division of Regional Medical Practice The Cleveland Clinic Foundation Cleveland, Ohio |
| Thomas A. Buchanan, MD | Professor of Medicine Professor of Obstetrics and Gynecology Professor of Physiology and Biophysics University of Southern California Keck School of Medicine Los Angeles, California |
| Mayer B. Davidson, MD | Professor of Medicine UCLA School of Medicine Los Angeles, California |
| Vivian A. Fonseca, MD | Professor of Medicine Director, Diabetes Program Tullis-Tulane Alumni Chair in Diabetes Tulane University Medical Center New Orleans, Louisiana |
| Saul M. Genuth, MD | Professor of Medicine Case Western Reserve University Endocrinologist University Hospitals of Cleveland Cleveland, Ohio |
| Henry N. Ginsberg, MD | Irving Professor of Medicine College of Physicians and Surgeons of Columbia University Director, Irving Center for Clinical Research NewYork–Presbyterian Hospital New York, New York |
| Silvio E. Inzucchi, MD |
Professor of Medicine |
| Virginia Peragallo-Dittko, APRN, BC-ADM, MA, CDE |
Clinical Associate Hunter College School of Nursing City University of New York New York, New York Director, Diabetes Education Center Winthrop-University Hospital Mineola, New York |
| James W. Reed, MD |
Professor of Medicine Associate Chair of Medicine for Research Morehouse School of Medicine Chief of Endocrinology Grady Memorial Hospital Atlanta, Georgia |
| Bernard Zinman, MDCM, FRCP(C), FACP |
Professor of Medicine Sam and Judy Pencer Chair in Diabetes University of Toronto Director, Leadership Sinai Centre for Diabetes Senior Scientist, Lunenfeld Research Institute Mount Sinai Hospital Toronto, Ontario |
|
